FDA Inspection
Patheon Italia S.p.APatheon Italia S.p.A – FDA Inspection, Feb 18, 2025
Record Details
This FDA Inspection record concerns Patheon Italia S.p.A, with an inspection on February 18, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 24528a03-9466-47c2-b9af-7cc7dad0300c
Inspection Facts
- Inspection number
- 1269289
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Patheon Italia S.p.A
13| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2026 | Not classified | Office of Inspections and Investigations | |
| June 14, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| February 17, 2017 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
Other documents for Patheon Italia S.p.A
- FDA Inspection 1306942 - 2026-01-30
- FDA Inspection 1174972 - 2022-06-14
- FDA Inspection 1247104 - 2022-02-25
- FDA Inspection 1066263 - 2018-09-21
- FDA Inspection 1008164 - 2017-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.